Acne Medication Market Outlook:
Acne Medication Market size was over USD 14.27 billion in 2025 and is poised to exceed USD 23.47 billion by 2035, growing at over 5.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of acne medication is estimated at USD 14.92 billion.
The rising prevalence of acne or skin disorders such as acne, eczema, and psoriasis is the prime reason fuelling the acne medication market. A 2023 report published by the World Health Organization (WHO) stated that skin conditions are estimated to impact 1.8 billion people at any point in time.
Antibiotics, retinoids, and isotretinoin are some medications used for acne treatment, wherein antibiotics are the most used drugs for acne treatment and are expected to exhibit high global demand throughout the forecast period. According to a report by the National Center for Biotechnology Information (NCBI) published in June 2023, the prevalence of acne among teenagers worldwide is around 80%. The same source also estimates that adult acne problem affects 40% of the population.
Additionally, companies are launching new formulations that combine existing ingredients with advanced delivery systems are also driving the acne medication market. For instance, in July 2024, Crown Laboratories announced that its brand PanOxyl has come with the latest innovations in acne-banishing body spray. Body sprays formulated with 2% salicylic acid are now aiding in clearing blemishes and unclogging pores more effectively, leading to long-lasting results.
